The E3 Ligase TRIM4 Facilitates SET Ubiquitin‐Mediated Degradation to Enhance ER‐ <i>α</i> Action in Breast Cancer-Reference-Cited by-全球学者库

The E3 Ligase TRIM4 Facilitates SET Ubiquitin‐Mediated Degradation to Enhance ER‐ α Action in Breast Cancer

Published:2022-07-17 Issue:25 Volume:9 Page:2201701
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Han Dianwen¹,Wang Lijuan²,Long Li¹³,Su Peng⁴,Luo Dan¹,Zhang Hanwen¹,Li Zheng¹,Chen Bing²,Zhao Wenjing²,Zhang Ning¹,Wang Xiaolong¹,Liang Yiran¹,Li Yaming¹,Hu Guohong⁵,Yang Qifeng¹²⁶^ORCID

Affiliation:

1. Department of Breast Surgery, General Surgery Qilu Hospital of Shandong University Jinan Shandong 250012 China

2. Pathology Tissue Bank Qilu Hospital of Shandong University JinanShandong250012 China

3. Mianyang Central Hospital School of Medicine University of Electronic Science and Technology of China Mianyang Sichuan 621000 China

4. Department of Pathology Qilu Hospital of Shandong University Jinan Shandong 250012 China

5. The Key Laboratory of Stem Cell Biology Institute of Health Sciences Shanghai Institutes for Biological Sciences Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine University of Chinese Academy of Sciences Shanghai 200233 China

6. Research Institute of Breast Cancer Shandong University Jinan Shandong 250012 China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

China Postdoctoral Science Foundation

Key Technology Research and Development Program of Shandong

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202201701

Reference85 articles.

1. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets

2. Breast cancer

3. US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status

4. Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

5. Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of deubiquitination in breast cancer;Gene;2024-04

2. SET protein as an epigenetics target;Epigenomics;2023-12-22

3. Cockayne syndrome patient iPSC-derived brain organoids and neurospheres show early transcriptional dysregulation of biological processes associated with brain development and metabolism;2023-10-17

4. The ubiquitin–proteasome system in breast cancer;Trends in Molecular Medicine;2023-08

5. The crosstalk between ubiquitination and endocrine therapy;Journal of Molecular Medicine;2023-03-24